Exosome RNA Exosome RNA Research & Industry News
Exosomes have been widely demonstrated as an effective anticancer therapeutic moiety. However, their clinical translation has been limited by the...
Read More »Anchor, spacer, and ligand-modified engineered exosomes for trackable targeted therapy
Exosomes as theranostics for lung cancer
Extensive research in genetics and genomics has revealed that lung cancer is a physiologically complex and genetically heterogeneous disease. Although molecular targets that can yield favorable response...
Read More »Recent advances in nanoparticle-based cancer drug and gene delivery
Effective and safe delivery of anticancer agents is among the major challenges in cancer therapy. The majority of anticancer agents are toxic to normal...
Read More »Exosomes are a mechanism of intercellular drug transfer
Exosomes are small membrane vesicles (30-100nm in diameter) secreted by cells into extracellular space. The present study evaluated the effect of chemotherapeutic agents on exosome production and/or release, and quantified the contribution of exosomes to intercellular drug transfer and pharmacodynamics. ...
Read More »Plasma exosome microRNAs are indicative of breast cancer
microRNAs are promising candidate breast cancer biomarkers due to their cancer-specific expression profiles. However, efforts to develop circulating breast cancer biomarkers are challenged by the heterogeneity of microRNAs in the blood. To overcome this challenge, researchers from the University of ...
Read More »Anti-cancer drug docosahexaenoic acid (DHA) alters breast cancer exosome secretion and microRNA contents
Docosahexaenoic acid (DHA) is a natural compound with anticancer and anti-angiogenesis activity that is currently under investigation as both a preventative agent and an adjuvant to breast cancer therapy. However, the precise mechanisms of DHA’s anticancer activities are unclear. It ...
Read More »